{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:45:57Z","timestamp":1788983157603,"version":"build-2803163510"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 AI148365-01A1"],"award-info":[{"award-number":["1R01 AI148365-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01OD026569"],"award-info":[{"award-number":["K01OD026569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012483","name":"University of Georgia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Invasive fungal infections cause over 1.5 million deaths worldwide. Despite increases in fungal infections as well as the numbers of individuals at risk, there are no clinically approved fungal vaccines. We produced a \u201cpan-fungal\u201d peptide, NXT-2, based on a previously identified vaccine candidate and homologous sequences from Pneumocystis, Aspergillus,Candida, and Cryptococcus. We evaluated the immunogenicity and protective capacity of NXT-2 in murine and nonhuman primate models of invasive aspergillosis, systemic candidiasis, and pneumocystosis. NXT-2 was highly immunogenic and immunized animals had decreased mortality and morbidity compared to nonvaccinated animals following induction of immunosuppression and challenge with Aspergillus, Candida, or Pneumocystis. Data in multiple animal models support the concept that immunization with a pan-fungal vaccine prior to immunosuppression induces broad, cross-protective antifungal immunity in at-risk individuals.<\/jats:p>","DOI":"10.1093\/pnasnexus\/pgac248","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T13:51:09Z","timestamp":1667569869000},"source":"Crossref","is-referenced-by-count":39,"title":["Immunogenicity and protective efficacy of a pan-fungal vaccine in preclinical models of aspergillosis, candidiasis, and pneumocystosis"],"prefix":"10.1093","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-3475","authenticated-orcid":false,"given":"Emily","family":"Rayens","sequence":"first","affiliation":[{"name":"Center for Vaccines and Immunology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Rabacal","sequence":"additional","affiliation":[{"name":"Center for Vaccines and Immunology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertine M E","family":"Willems","sequence":"additional","affiliation":[{"name":"Center for Vaccines and Immunology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle M","family":"Kirton","sequence":"additional","affiliation":[{"name":"Center for Vaccines and Immunology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Barber","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4709-2478","authenticated-orcid":false,"given":"Jarrod J","family":"Mousa","sequence":"additional","affiliation":[{"name":"Center for Vaccines and Immunology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi N","family":"Celia-Sanchez","sequence":"additional","affiliation":[{"name":"Fungal Biology Group, Department of Plant Biology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-063X","authenticated-orcid":false,"given":"Michelle","family":"Momany","sequence":"additional","affiliation":[{"name":"Fungal Biology Group, Department of Plant Biology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A","family":"Norris","sequence":"additional","affiliation":[{"name":"Center for Vaccines and Immunology, University of Georgia , Athens, GA 30602, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"issue":"4","key":"2022121308564168300_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases-estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J Fungi"},{"issue":"1","key":"2022121308564168300_bib2","doi-asserted-by":"crossref","first-page":"ofab593","DOI":"10.1093\/ofid\/ofab593","article-title":"Prevalence and healthcare burden of fungal infections in the United States, 2018","volume":"9","author":"Rayens","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"8","key":"2022121308564168300_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2022121308564168300_bib4","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2022121308564168300_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijantimicag.2011.11.017","article-title":"Invasive fungal infections in patients with cancer in the intensive care unit","volume":"39","author":"Sipsas","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2022121308564168300_bib6","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar4480","article-title":"Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responses","volume":"16","author":"Bishu","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"2022121308564168300_bib7","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3899\/jrheum.111498","article-title":"Invasive fungal infections in patients with systemic lupus erythematosus","volume":"39","author":"Martinez-Martinez","year":"2012","journal-title":"J Rheumatol"},{"issue":"12","key":"2022121308564168300_bib8","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3899\/jrheum.150142","article-title":"A multicenter study of invasive fungal infections in patients with childhood-onset systemic lupus erythematosus","volume":"42","author":"Silva","year":"2015","journal-title":"J Rheumatol"},{"issue":"24","key":"2022121308564168300_bib9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM198112103052402","article-title":"An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction","volume":"305","author":"Masur","year":"1981","journal-title":"N Engl J Med"},{"issue":"8","key":"2022121308564168300_bib10","doi-asserted-by":"crossref","first-page":"ofy187","DOI":"10.1093\/ofid\/ofy187","article-title":"Epidemiology and clinical features of invasive fungal infection in a US health care network","volume":"5","author":"Webb","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2022121308564168300_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3201\/eid2701.202896","article-title":"Aspergillosis complicating severe coronavirus disease","volume":"27","author":"Marr","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2022121308564168300_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/myc.13254","article-title":"COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series","volume":"64","author":"Meijer","year":"2021","journal-title":"Mycoses"},{"key":"2022121308564168300_bib13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal","year":"2021","journal-title":"Mycoses"},{"issue":"8","key":"2022121308564168300_bib14","doi-asserted-by":"crossref","first-page":"e1008742","DOI":"10.1371\/journal.ppat.1008742","article-title":"Post-tuberculosis chronic pulmonary aspergillosis: an emerging public health concern","volume":"16","author":"Bongomin","year":"2020","journal-title":"PLoS Pathog"},{"issue":"6","key":"2022121308564168300_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","article-title":"Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment","volume":"31","author":"Vanderbeke","year":"2018","journal-title":"Curr Opin Infect Dis"},{"key":"2022121308564168300_bib16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/CCM.0000000000004861","article-title":"The extent of Aspergillosis in critically ill patients with severe influenza pneumonia: a multicenter cohort study","volume":"49","author":"Coste","year":"2021","journal-title":"Crit Care Med"},{"key":"2022121308564168300_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/ciab336","article-title":"Mortality trends in risk conditions and invasive mycotic disease in the United States, 1999-2018","volume":"74","author":"Rayens","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022121308564168300_bib18","article-title":"Fungal disease frequency","author":"GAFFI"},{"issue":"3","key":"2022121308564168300_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2022121308564168300_bib20","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3201\/eid2106.140717","article-title":"Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus","volume":"21","author":"van\u00a0der\u00a0Linden","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2022121308564168300_bib21","doi-asserted-by":"crossref","first-page":"e01564","DOI":"10.1128\/JCM.01564-17","article-title":"Update from a 12-year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern","volume":"56","author":"Astvad","year":"2018","journal-title":"J Clin Microbiol"},{"issue":"Pt 2","key":"2022121308564168300_bib22","doi-asserted-by":"crossref","first-page":"158284","DOI":"10.1016\/j.scitotenv.2022.158284","article-title":"Effectiveness of front line and emerging fungal disease prevention and control interventions and opportunities to address appropriate eco-sustainable solutions","volume":"851","author":"Garvey","year":"2022","journal-title":"Sci Total Environ"},{"issue":"5","key":"2022121308564168300_bib23","doi-asserted-by":"crossref","first-page":"55001","DOI":"10.1289\/EHP7484","article-title":"Trends in agricultural triazole fungicide use in the United States, 1992-2016 and possible implications for antifungal-resistant fungi in human disease","volume":"129","author":"Toda","year":"2021","journal-title":"Environ Health Perspect"},{"issue":"6","key":"2022121308564168300_bib24","doi-asserted-by":"crossref","first-page":"FSO307","DOI":"10.4155\/fsoa-2018-0019","article-title":"Invasive fungal infections in high-risk patients: report from TIMM-8 2017","volume":"4","author":"Pagano","year":"2018","journal-title":"Future Sci OA"},{"issue":"9","key":"2022121308564168300_bib25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2217\/fmb.11.85","article-title":"Update on invasive fungal disease","volume":"6","author":"Pagano","year":"2011","journal-title":"Fut Microbiol"},{"issue":"1","key":"2022121308564168300_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.hoc.2010.11.013","article-title":"Fungal infections in transplant and oncology patients","volume":"25","author":"Person","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"issue":"1","key":"2022121308564168300_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/595297","article-title":"Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques","volume":"199","author":"Kling","year":"2009","journal-title":"J Infect Dis"},{"issue":"12","key":"2022121308564168300_bib28","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1172\/JCI26306","article-title":"CD4+ T cell-independent DNA vaccination against opportunistic infections","volume":"115","author":"Zheng","year":"2005","journal-title":"J Clin Invest"},{"issue":"4","key":"2022121308564168300_bib29","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1128\/IAI.74.4.2446-2448.2006","article-title":"Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen","volume":"74","author":"Wells","year":"2006","journal-title":"Infect Immun"},{"issue":"10","key":"2022121308564168300_bib30","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/infdis\/jiw032","article-title":"Vaccine-induced immunogenicity and protection against pneumocystis pneumonia in a nonhuman primate model of HIV and pneumocystis coinfection","volume":"213","author":"Kling","year":"2016","journal-title":"J Infect Dis"},{"issue":"3","key":"2022121308564168300_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0b013e3182167516","article-title":"Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia","volume":"57","author":"Gingo","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"2022121308564168300_bib32","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1128\/IAI.00507-10","article-title":"Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection","volume":"78","author":"Kling","year":"2010","journal-title":"Infect Immun"},{"key":"2022121308564168300_bib33","doi-asserted-by":"crossref","first-page":"670578","DOI":"10.3389\/fimmu.2021.670578","article-title":"Vaccine-induced protection in two murine models of invasive pulmonary aspergillosis","volume":"12","author":"Rayens","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"2022121308564168300_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat Methods"},{"issue":"3","key":"2022121308564168300_bib35","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1371\/journal.ppat.0010030","article-title":"Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display","volume":"1","author":"Hohl","year":"2005","journal-title":"PLoS Pathog"},{"issue":"8","key":"2022121308564168300_bib36","doi-asserted-by":"crossref","first-page":"e1007460","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection","volume":"15","author":"Singh","year":"2019","journal-title":"PLoS Pathog"},{"issue":"3","key":"2022121308564168300_bib37","first-page":"643","article-title":"A new and clinically relevant murine model of solid-organ transplant aspergillosis","volume":"6","author":"Herbst","year":"2013","journal-title":"Dis Model Mech"},{"issue":"133","key":"2022121308564168300_bib38","first-page":"57155","article-title":"Histological quantification to determine lung fungal burden in experimental aspergillosis","volume":"9","author":"Stolz","year":"2018","journal-title":"J Vis Exp"},{"issue":"1","key":"2022121308564168300_bib39","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1080\/22221751.2020.1771218","article-title":"Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model","volume":"9","author":"Forgacs","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2022121308564168300_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2334-6-55","article-title":"Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases","volume":"6","author":"Zuluaga","year":"2006","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2022121308564168300_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/aid.2018.0132","article-title":"Monocyte and alveolar macrophage skewing is associated with the development of pulmonary arterial hypertension in a primate model of HIV infection","volume":"35","author":"Schweitzer","year":"2019","journal-title":"AIDS Res Hum Retrovirus"},{"issue":"2","key":"2022121308564168300_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/653485","article-title":"Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS","volume":"202","author":"Shipley","year":"2010","journal-title":"J Infect Dis"},{"issue":"4","key":"2022121308564168300_bib43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1086\/373997","article-title":"Experimental Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques","volume":"187","author":"Board","year":"2003","journal-title":"J Infect Dis"},{"issue":"8713","key":"2022121308564168300_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0140-6736(90)92008-6","article-title":"Detection of Pneumocystis carinii with DNA amplification","volume":"336","author":"Wakefield","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"2022121308564168300_bib45","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/088922202753519179","article-title":"Alterations in T lymphocyte profiles of bronchoalveolar lavage fluid from SIV- and Pneumocystis carinii-coinfected rhesus macaques","volume":"18","author":"Croix","year":"2002","journal-title":"AIDS Res Hum Retrovirus"},{"issue":"2","key":"2022121308564168300_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1164\/ajrccm\/143.2.437","article-title":"Reversed helper\/suppressor T-lymphocyte ratio in bronchoalveolar lavage fluid from patients with breast cancer and Pneumocystis carinii pneumonia","volume":"143","author":"Siminski","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"9","key":"2022121308564168300_bib47","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1080\/21645515.2019.1631135","article-title":"Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates","volume":"15","author":"Cobos\u00a0Jimenez","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"2022121308564168300_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1513\/pats.200501-003AW","article-title":"T cell memory in the lung airways","volume":"2","author":"Woodland","year":"2005","journal-title":"Proc Am Thorac Soc"},{"issue":"5","key":"2022121308564168300_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"2022121308564168300_bib50","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chom.2015.02.009","article-title":"Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopes","volume":"17","author":"Wuthrich","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"6","key":"2022121308564168300_bib51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/1060028014529928","article-title":"Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics","volume":"48","author":"Aitken","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"2","key":"2022121308564168300_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/CMR.00013-12","article-title":"Colonization by Pneumocystis jirovecii and its role in disease","volume":"25","author":"Morris","year":"2012","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"2022121308564168300_bib53","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1086\/591701","article-title":"Relationship of pneumocystis antibody response to severity of chronic obstructive pulmonary disease","volume":"47","author":"Morris","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2022121308564168300_bib54","doi-asserted-by":"crossref","first-page":"e000842","DOI":"10.1136\/bmjresp-2020-000842","article-title":"Relationship of Pneumocystis antibody responses to paediatric asthma severity","volume":"8","author":"Rayens","year":"2021","journal-title":"BMJ Open Respir Res"},{"issue":"4","key":"2022121308564168300_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"issue":"5-6","key":"2022121308564168300_bib56","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0264-410X(02)00407-3","article-title":"Memory T cells and vaccines","volume":"21","author":"Esser","year":"2003","journal-title":"Vaccine"},{"key":"2022121308564168300_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.fgb.2015.02.006","article-title":"Kexin-like endoprotease KexB is required for N-glycan processing, morphogenesis and virulence in Aspergillus fumigatus","volume":"76","author":"Wang","year":"2015","journal-title":"Fungal Genet Biol"},{"issue":"12","key":"2022121308564168300_bib58","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1128\/iai.59.12.4459-4464.1991","article-title":"Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells","volume":"59","author":"Gomez","year":"1991","journal-title":"Infect Immun"}],"container-title":["PNAS Nexus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pnasnexus\/advance-article-pdf\/doi\/10.1093\/pnasnexus\/pgac248\/46796931\/pgac248.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pnasnexus\/article-pdf\/1\/5\/pgac248\/47260571\/pgac248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pnasnexus\/article-pdf\/1\/5\/pgac248\/47260571\/pgac248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T04:01:50Z","timestamp":1670904110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pnasnexus\/article\/doi\/10.1093\/pnasnexus\/pgac248\/6798391"}},"subtitle":[],"editor":[{"given":"Ian","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pnasnexus\/pgac248","relation":{},"ISSN":["2752-6542"],"issn-type":[{"value":"2752-6542","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11]]},"published":{"date-parts":[[2022,11,1]]},"article-number":"pgac248"}}